Company news
Rznomics Inc. (KRX:476830) news
Every Rznomics Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Rznomics Reports Major Advances in High-Efficiency Circular RNA Production in Nucleic Acids Research
September 7, 2026
Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics
August 23, 2026
Rznomics Announces U.S. FDA Regenerative Medicine Advanced Therapy Designation Granted to 'RZ-001' for Hepatocellular Carcinoma
May 8, 2026
Rznomics Reports Interim Clinical Data for RZ-001 in Hepatocellular Carcinoma at AACR 2026 Demonstrating Encouraging Efficacy and Favorab...
April 20, 2026